Standard BioTools
LAB
LAB
145 hedge funds and large institutions have $719M invested in Standard BioTools in 2024 Q1 according to their latest regulatory filings, with 72 funds opening new positions, 47 increasing their positions, 13 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
69% more funds holding
Funds holding: 86 → 145 (+59)
25.84% more ownership
Funds ownership: 65.62% → 91.46% (+26%)
Holders
145
Holding in Top 10
4
Calls
$3.11M
Puts
$1K
Top Buyers
| 1 | +$165M | |
| 2 | +$159M | |
| 3 | +$35.3M | |
| 4 |
Millennium Management
New York
|
+$34.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$24.1M |
Top Sellers
| 1 | -$15.6M | |
| 2 | -$4.14M | |
| 3 | -$1.29M | |
| 4 |
Morgan Stanley
New York
|
-$649K |
| 5 |
HI
HBK Investments
Dallas,
Texas
|
-$333K |